Stay updated with breaking news from Christoph Correll. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Switching to UZEDY at four weeks after the last dose of once-monthly paliperidone palmitate provided the most comparable pharmacokinetic profile based on the relevant PK modeling data Additional...
These results were instrumental in securing the FDA approval of the drug for the treatment of schizophrenia in adults in April 2023.
New 3-year analysis shows a significant rate of patients were able to avoid relapse or hospitalization while receiving the long-acting injectable.
Proportion of adolescents with autism or intellectual disability has increased among youths treated with these medications.
Hundreds of aging research, drug discovery professionals, and clinicians convened in Copenhagen for the Longevity Medicine Day at the 10th ARDD.